Keywords: مقاومت درمانی; Treatment resistance; Clozapine; Schizophrenia; Validation; Sensitivity; Specificity; Positive predictive value; Negative predictive value;
مقالات ISI مقاومت درمانی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: مقاومت درمانی; Schizophrenia; Auditory hallucinations; Treatment resistance; Psychotherapy; Virtual reality; Avatar;
Keywords: مقاومت درمانی; MDD; major depressive disorder; GAD; generalized anxiety disorder; QIDS-SR; Quick Inventory of Depressive Symptoms; Q-LES-Q-SF; Quality of Life Enjoyment and Satisfaction Questionnaire Short Form; UKU; Udvalg for Kliniske Undersøgelser Side Effect Rating
Keywords: مقاومت درمانی; Geriatric/Aging/Elderly; Depression; Pharmacoepidemiology; Pharmacotherapy; Treatment resistance;
Keywords: مقاومت درمانی; Schizophrenia; Treatment resistance; Treatment response; Magnetic resonance imaging; Network based statistics; Clozapine;
Keywords: مقاومت درمانی; Deep brain stimulation; Major depression; Bed nucleus of the stria terminalis; Clinical response; Treatment resistance;
Keywords: مقاومت درمانی; Breast cancer; Macrophage; Tumor microenvironment; Treatment resistance; Targeted therapy;
Keywords: مقاومت درمانی; Network analysis; Feature selection; Classification; Treatment resistance; Schizophrenia;
Keywords: مقاومت درمانی; Glioblastoma; MGMT; Repositioning of drugs; Precision medicine; Biomarker; Radiomics; Treatment resistance; Immunotherapy;
Keywords: مقاومت درمانی; Bipolar disorders; Lithium; Discontinuation; Long term treatment; Unresponsiviness; Response; Treatment resistance;
Keywords: مقاومت درمانی; Antipsychotics; Long-acting injections; Treatment resistance; Schizophrenia; Bipolar disorder;
Keywords: مقاومت درمانی; Treatment resistance; Cancer stem cells; Cancer progression; Mutation; EMT; EMT transition; ABCB1; ATP-binding cassette, Sub-family B, Member 1; ABCG2; ATP-binding cassette, Sub-family G, Member 2; AKT; V-Akt murine thymoma viral oncogene; APC; adenomatou
Keywords: مقاومت درمانی; Corticosteroids; cyclophosphamide; minimal change disease (MCD); nephrotic syndrome (NS); immunosuppression; adult-onset MCNS; adults; adolescents; partial remission; complete remission; treatment resistance; relapse; renal survival; acute kidney injury (
Keywords: مقاومت درمانی; Accelerated iTBS; Functional connectivity; Major depressive disorder; Orbitofrontal cortex; Subgenual anterior cingulate cortex; Treatment resistance;
Keywords: مقاومت درمانی; Treatment resistance; Depression; Short-term; Psychodynamic Psychotherapy; Randomised trial;
Keywords: مقاومت درمانی; Sleep disorders; Sleep apnea; Excessive daytime sleepiness; Persistent sleepiness; Hypersomnolence; Hypersomnia; Therapy; Treatment resistance;
Keywords: مقاومت درمانی; Schizophrenia; Treatment resistance; Urbanicity; Antipsychotics; Clozapine;
Keywords: مقاومت درمانی; Accelerated rTMS; Intermittent theta-burst stimulation; Treatment resistance; Left DLPFC; Major depression;
Keywords: مقاومت درمانی; Schizophrenia; Treatment resistance; Non-response; High-dose treatment; Antipsychotic drugs;
Keywords: مقاومت درمانی; Depression; Cognitive behavioural therapy; Treatment resistance; Moderators; Stratified medicine; Primary care;
Keywords: مقاومت درمانی; Short-term; Treatment resistance; Anxiety; Depression; Personality disorder; Psychodynamic psychotherapy
Keywords: مقاومت درمانی; Zebrafish; Treatment resistance; Seizures; Epilepsy; Allylglycine; Antiepileptic drugs;
Keywords: مقاومت درمانی; Mutational timing; Intratumour heterogeneity; Cancer evolution; Subclonal mutations; Treatment resistance;
Keywords: مقاومت درمانی; Psychotherapy; Psychosocial treatment; Treatment resistance; Epigenetics; Comorbidity; Early adversity; Personality disorders; Parity;
Keywords: مقاومت درمانی; Nonconvulsive; Subconvulsive; Electrotherapy; Electroconvulsive; Depression; Treatment resistance;
Keywords: مقاومت درمانی; Quality of life; Antidepressant; TMS; Clinical trial; Major depression; Treatment resistance;
Keywords: مقاومت درمانی; Treatment-refractory depression; Antidepressant treatment history form; Antidepressant treatment; Treatment resistance;
Keywords: مقاومت درمانی; TRD; treatment-resistant depression; TSD; treatment-sensitive depression; FC; functional connectivity; PFC; prefrontal cortex; MFG; middle frontal gyrus; SMA; supplementary motor area; ITG; inferior temporal gyrus; IPL; inferior parietal lobule; MDD; majo
Keywords: مقاومت درمانی; Schizophrenia; Clozapine; Treatment resistance
Keywords: مقاومت درمانی; Schizophrenia; Treatment resistance; Cognition; Antipsychotics; Anticholinergic effect
Keywords: مقاومت درمانی; Corticosterone; Fluoxetine; Neurogenesis; Anxiety; Stress; Treatment resistance
Substantia nigra ultrastructural pathology in schizophrenia
Keywords: مقاومت درمانی; Mitochondria; Myelin; Axons; Treatment resistance; Postmortem;
A P2X7 receptor antagonist reverses behavioural alterations, microglial activation and neuroendocrine dysregulation in an unpredictable chronic mild stress (UCMS) model of depression in mice
Keywords: مقاومت درمانی; P2X7; Neuroinflammation; Unpredictable chronic mild stress (UCMS); Major depressive disorder (MDD); Neuroendocrine HPA axis; Neurogenesis; Antidepressant pharmacotherapy; Treatment resistance; Microglia; Radioimmunoassay (RIA);
Pharmacogenetics of androgen signaling in prostate cancer: Focus on castration resistance and predictive biomarkers of response to treatment
Keywords: مقاومت درمانی; Castration resistant prostate cancer; Tumor heterogeneity; Androgen receptor; Treatment resistance; Predictive biomarkers;
Capturing tumor heterogeneity and clonal evolution in solid cancers using circulating tumor DNA analysis
Keywords: مقاومت درمانی; Cell-free DNA; Circulating tumor DNA; Clonal evolution; Tumor heterogeneity; Treatment resistance; cfDNA; cell-free DNA; ctDNA; circulating tumor DNA;
Original ArticleRapid selection of BRCA1-proficient tumor cells during neoadjuvant therapy for ovarian cancer in BRCA1 mutation carriers
Keywords: مقاومت درمانی; BRCA1; Ovarian cancer; Neoadjuvant therapy; Loss-of-heterozygosity; Treatment resistance; HRM; high-resolution melting; IDS; interval debulking surgery; IHC; immunohistochemistry; LOH; loss-of-heterozygosity; NACT; neoadjuvant chemotherapy; OC; ovarian ca
ReviewStem cells and the role of ETS transcription factors in the differentiation hierarchy of normal and malignant prostate epithelium
Keywords: مقاومت درمانی; Prostate cancer; Cancer stem cells; ETS factors; Treatment resistance;
Analytical Validation and Clinical Qualification of a New Immunohistochemical Assay for Androgen Receptor Splice Variant-7 Protein Expression in Metastatic Castration-resistant Prostate Cancer
Keywords: مقاومت درمانی; Androgen receptor; Androgen receptor variant-7; Castration-resistant prostate cancer; Metastatic biopsy; Treatment resistance; Predictor of outcome;
Impact of Prior Treatment on Remission of Late-Life Depression with Venlafaxine and Subsequent Aripiprazole or Placebo Augmentation
Keywords: مقاومت درمانی; Geriatric depression; antidepressant; treatment resistance; augmentation; venlafaxine; aripiprazole; randomized controlled trial;
Emotion processing in treatment-resistant schizophrenia patients treated with clozapine: An fMRI study
Keywords: مقاومت درمانی; Emotion; Schizophrenia; Treatment resistance; Clozapine; fMRI;
Pilot study of feasibility of the effect of treatment with tDCS in patients suffering from treatment-resistant depression treated with escitalopram
Keywords: مقاومت درمانی; Transcranial direct current stimulation; Depression; Treatment resistance;
Augmentative repetitive Transcranial Magnetic Stimulation (rTMS) in the acute treatment of poor responder depressed patients: A comparison study between high and low frequency stimulation
Keywords: مقاومت درمانی; Repetitive transcranial magnetic stimulation (rTMS); Augmentation; Poor drug response; Treatment resistance; Major depressive disorder; Bipolar disorder;
Oral Debio1143 (AT406), an Antagonist of Inhibitor of Apoptosis Proteins, Combined With Daunorubicin and Cytarabine in Patients With Poor-Risk Acute Myeloid Leukemia—Results of a Phase I Dose-Escalation Study
Keywords: مقاومت درمانی; cIAP1; Interleukin; Pharmacokinetics; Treatment resistance; TNF
S-adenosylmethionine (SAMe) and Magnesium Orotate as adjunctives to SSRIs in sub-optimal treatment response of depression in adults: A pilot study
Keywords: مقاومت درمانی; Depression; SSRI; SAMe; Treatment resistance; Relapse; GIT; Dysbiosis
Disruption of thioredoxin metabolism enhances the toxicity of transforming growth factor β-activated kinase 1 (TAK1) inhibition in KRAS-mutated colon cancer cells
Keywords: مقاومت درمانی; TAK1; KRAS; Colorectal cancer; Thioredoxin; Treatment resistance
The VA augmentation and switching treatments for improving depression outcomes (VAST-D) study: Rationale and design considerations
Keywords: مقاومت درمانی; Study design; Methodology; Major depression; Antidepressants; Antipsychotics; Treatment resistance
The Use of Narrative Strategies Based on Fairytales as a Novel, Integrative Ingredient in CBT: A Case Report
Keywords: مقاومت درمانی; Narrative therapy; CBT; fairytales; psychotherapy; treatment resistance
Self-directedness: An indicator for clinical response to the HF-rTMS treatment in refractory melancholic depression
Keywords: مقاومت درمانی; Self-directedness; HF-rTMS; Unipolar depression; Melancholia; Treatment resistance;
Effectiveness and clinical predictors of response to combined ECT and antipsychotic therapy in patients with treatment-resistant schizophrenia and dominant negative symptoms
Keywords: مقاومت درمانی; Treatment resistance; Schizophrenia; Electroconvulsive therapy; Antipsychotics;
Differential expression of hippocampal EphA4 and ephrinA3 in anhedonic-like behavior, stress resilience, and antidepressant drug treatment after chronic unpredicted mild stress
Keywords: مقاومت درمانی; Chronic unpredicted mild stress; Stress resilience; Treatment resistance; EhpA4; ephrinA3; Depression; CUMS; chronic unpredictable mild stress; EphA4; EPH receptor A4; ephrinA3; Eph receptor-interacting proteins A3; MDD; major depressive disorder; GLT1; g